Preview

Epidemiology and Vaccinal Prevention

Advanced search

The Impact of the Introduction of Clinical Recommendations on Cardiology in the USA and Russia Federetionon Mortality from Ischemic Heart Diseas

https://doi.org/10.31631/2073-3046-2018-17-4-30-37

Abstract

1 million 824 thousand people died in the Russian Federation in 2017, including 457 thousand from ischemic heart disease (IHD). IHD caused more than a quarter of deaths in Russia. Goal. The article analyzes the impact of implementation of clinical guidelines in cardiology in medical practice in the United States and the Russian Federation on the dynamics of mortality from ischemic heart disease and its outcomes in different age groups. Results. The results showed that the implementation of clinical guidelines (CG) increased the rate of mortality reduction from coronary heart diseases in Russia and the United States, which may indicate a positive impact CG on the quality of medical care. Conclusions. A higher level of mortality from coronary heart disease in Russia compared to the United States may be due to less commitment of doctors to the principles of therapy and diagnosis of various forms of coronary heart disease, set out in clinical guidelines.

About the Author

A. A. Gerasimov
Sechenov University
Russian Federation

Andrey A. Gerasimov – postgraduate student of the Department of Epidemiology and Evidence-Based Medicine, First Moscow State Medical University them I. M. Sechenov Ministry of Healthcare of Russia (Sechenov University)

Moscow 



References

1. Kutishenko N. P., Tolpygin, S. N., Lukin, Yu., kontsevaya A.V., Lichota A. S., Ivanova A. P., and others. the Efficacy and safety of drug therapy in primary and secondary prevention of cardiovascular diseases. Rational pharmacotherapy in cardiology. 2011; 7 (5s): 2–72 (in Russian).

2. Kontsevaya A. V., Kalinina M. A., Koltunov I. E., Oganov R. G. Socio-economic harm from acute coronary syndrome in the Russian Federation. Rational pharmacotherapy in cardiology. 2011; 7 (2): 158–166 (in Russian).

3. Gerasimov A. A., Polibin R. V., Mindlina A. YA. The compliance of the outpatient physicians to the clinical guidelines for the prevention of the recurrent myocardial infarction. [Epidemiology of infectious diseases]. 2017; 3: 25–30 (in Russian).

4. Oganov, R. G. fundamentals of evidence-based medicine in cardiology. Medical business. 2007; 2: 3–11. (in Russian).

5. Samorodskaya I. V., Stepchenko, V. I., Butrova Y. V., Saversky A.V. Standards of medical care in Russia and the United States. Health manager. 2015; 4: 46–54 (in Russian).

6. ACC/AHA guidelines for the management of patients with acute myocardial infarction: A report of the American College of cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). J Am Coll Cardiol. 1996; 28 (5): 1328–428.

7. Gibbons RJ, Chatterjee K, Daley J, Douglas JS, Fihn SD, Gardin JM et al. ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: executive summary and recommendations. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients with Chronic Stable Angina). Circulation. 1999; 99: 2829–2848.

8. ACC/AHA guidelines for percutaneous coronary intervention (revision of the 1993 PTCA guidelines)-executive summary: a report of the American College of Cardiology/ American Heart Association task force on practice guidelines (Committee to revise the 1993 guidelines for percutaneous transluminal coronary angioplasty) endorsed by the Society for Cardiac Angiography and Interventions. Circulation. 2001; 103: 3019–3041.

9. Moiseev B. C., Tereshchenko S. N., Pavlikova E. P., Yavelov I. S. National recommendations for the diagnosis and treatment of acute heart failure. Cardiovascular therapy and prevention. 2006; 5 (in Russian).

10. National guidelines for the diagnosis and treatment of patients with acute myocardial infarction with ST-segment elevation of the ECG. Cardiovascular therapy and prevention 2007; 6: 415–500 (in Russian).

11. Task Force Members, Silber S., Albertsson P., Francisco F. Avilés, Paolo G. et al. Guidelines for Percutaneous Coronary Interventions: The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology// European Heart Journal. 2005: 804–847.

12. Suvorov, A., Martsevich S. Yu., Kutishenko N. P., Deev A. D., Ginzburg, M. L. Assessment of compliance with current clinical guidelines of cardiovascular therapy to improve outcomes in patients after a stroke (according to the register LIS-2). Rational pharmacotherapy in cardiology. 2015: 11 (3); 247 –252 (in Russian).

13. Briko N. I., brusina, Zueva L. P., Efimov, O. Kovalishin, V., Stasenko V. L., etc., the Criteria of epidemiological safety of medical care. Medical almanac. 2014; 4: 8–13 (in Russian).

14. Syrkina A. G., Belokopytova, N. V. Markov, V. Erlich A. D. how National clinical guidelines for the treatment of acute coronary syndrome with ST-segment elevation in the middle urbanized city of Siberia are implemented according to the Record-2 register. Siberian medical journal. 2013: 28 (3); 19–24 (in Russian).


Review

For citations:


Gerasimov A.A. The Impact of the Introduction of Clinical Recommendations on Cardiology in the USA and Russia Federetionon Mortality from Ischemic Heart Diseas. Epidemiology and Vaccinal Prevention. 2018;17(4):30-37. (In Russ.) https://doi.org/10.31631/2073-3046-2018-17-4-30-37

Views: 1267


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2073-3046 (Print)
ISSN 2619-0494 (Online)